Osler, Hoskin & Harcourt LLP advised Inversago Pharma on the matter. On August 10, 2023, Inversago Pharma announced its business combination with Nova Nordisk for US$1.075...
You must be a Standard 1 Year member to access this content.
Osler, Hoskin & Harcourt LLP advised CDPQ on the equity investment in Pomerleau Inc. On December 7, 2022, Caisse de dépôt et Placement du Québec (“CDPQ”)...
You must be a Standard 1 Year member to access this content.
Osler, Hoskin & Harcourt LLP advised Connektica on the round. On October 31, 2022, Connektica announced it had closed its $2.7 million seed round that saw...
You must be a Standard 1 Year member to access this content.
Fasken supported NuChem Sciences Inc. on the acquisition of IniXium Inc., assisted by Osler, Hoskin & Harcourt LLP. Blakes represented the Fonds de solidarité FTQ. NuChem...
You must be a Standard 1 Year member to access this content.
